Gerresheimer is a specialist for primary packaging for biologics

Düsseldorf/Paris January 30, 2020. The most important trend fore-cast by pharmaceutical experts is the continuing, worldwide increasing demand for biological drugs and biosimilars. With the recently founded, Gx Biological Solutions organization, Gerresheimer installed a dedicated team to serve the highly specific demands in the Biological playfield.

The global biopharmaceuticals market is driven by various factors, such as the increase in elderly population, surge in prevalence of chronic diseases like cancer and diabetes and growth in the adoption of biopharmaceuticals globally. Furthermore, a rise in strategic collaborations among biopharmaceuticals companies is also anticipated to supplement the growth of the biopharmaceuticals industry.

Biological drugs are specifically being used to treat e.g. rheumatism, diabetes or cancer and are usually administered parenterally. They differ from conventional drugs in their molecular structure, hence special demands on the primary packaging are to be taken care of. Gerresheimer has developed a complete package of services and products for these biological drugs and biosimilars. This includes a dedicated innovative product portfolio consisting of specialty syringes and vials, safety devices, etc. that meet the specific requirements of this continuously growing market segment. At the same time, Gerresheimer also offers a wide range of services, especially for small and medium-sized biotech companies. Whether it is advice on the right primary packaging to be used in the appropriate clinical phase or support with approval and regulatory processes, lab services and much more.

Gx Biological Solutions – new founded team of specialists

At Pharmapack in Paris, Gerresheimer will present its products for the safe, innovative and sustainable packaging of biologicals. "We want to provide our customers in the pharmaceutical industry with customized packaging solutions for their biologics so that they can be assured that all of their requirements are met 100 percent" said Stefan Verheyden, Global Vice President of the new founded Gx Biological Solutions team.

Small Batch Production in Germany

As a leading manufacturer of syringes, injection vials as well as cartridges and administration systems, Gerresheimer covers a very broad spectrum for the parenteral administration of biologicals within its portfolio. Smaller batch sizes are often requested when filling biological products, hence Gerresheimer has invested in small batch production facility in Wackersdorf – Germany. When the filled biological agent is sensitive to its storage environment, the container must be individually adapted to its properties. During the clinical development phase, Gerresheimer experts can support with advice on the right primary packaging, syringe or drug delivery device, as well as with regulatory approval processes and much more.

Workshop: Pack and administer biologics safely

Information about tailor-made and safe solutions for biologics is available at the Pharmapack on the Gerresheimer booth and in addition on February 6th at 10 a.m. in a workshop with Dr. Wenzel Novak and Amir Tahric from Gerresheimer.

Gerresheimer at the Pharmapack 2020 in Paris

Gerresheimer will present its sustainable and innovative packaging and administration solutions at the Pharmapack in Paris on February 5 and 6 at booth B60/B64.

About Gerresheimer

Gerresheimer is a leading global partner to the pharma and healthcare industry. With specialty glass and plastic products, the Company contributes to health and well-being. Gerresheimer operates worldwide and its approximately 10,000 employees manufacture products in local markets, close to its customers. With our plants in Europe, North America, South America, and Asia, we generate revenues of approximately EUR 1.4 billion. Our comprehensive product portfolio includes pharmaceutical packaging and products for the safe, simple administration of medicines: insulin pens, inhalers, micro pumps, prefillable syringes, injection vials, ampoules, bottles, and containers for liquid and solid medicines with closure and safety systems as well as packaging for the cosmetics industry.

Back to overview